Inventor
XIANG SHAO
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C07KPeptides16%
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
C12NMicroorganisms or enzymes12%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture12%
Y02ATechnologies for adaptation to climate change12%
PatentTitleYear
12,077,584Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)202411,981,734Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)202411,466,092Antibodies against OX-40 and uses thereof202211,274,150Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to BRISTOL MYERS SQUIBB CO (4)· patent assignee history
2022–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 4 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2022–2024 |